Key result
Catheter-based treatment of acute venous thromboembolism may reduce postthrombotic sequelae and improve quality of life, though bleeding events remain frequent at low-volume centers.
Catheter-based treatment for acute VTE is a viable adjunct to anticoagulation, but protocols need standardization to reduce bleeding complications.
May support catheter-based adjuncts for acute VTE at high-volume centers; leaves open need for standardized protocols and randomized trials.
OBJECTIVE: The purpose of this article is to describe the indications for and approach to catheter-based treatment of acute venous thromboembolism (VTE). CONCLUSION: Catheter-based treatment of VTE is a viable adjunct to anticoagulant therapy and is being rapidly adopted around the United States. Early data suggest that these therapies reduce postthrombotic sequelae and improve quality of life, but bleeding events are still frequent, particularly at low-volume centers. Protocols need to be standardized to improve patient care.
No takes yet. Share an insight, caveat, or question.
Jarrett et al. (2017) conducted a review in Acute venous thromboembolism (VTE). Catheter-based treatment was evaluated. Catheter-based treatment of acute venous thromboembolism may reduce postthrombotic sequelae and improve quality of life, though bleeding events remain frequent at low-volume centers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: